Literature DB >> 33293360

Chondroitinase and Antidepressants Promote Plasticity by Releasing TRKB from Dephosphorylating Control of PTPσ in Parvalbumin Neurons.

Angelina Lesnikova1, Plinio Cabrera Casarotto1, Senem Merve Fred1, Mikko Voipio1, Frederike Winkel1, Anna Steinzeig1, Hanna Antila1, Juzoh Umemori1, Caroline Biojone2, Eero Castrén2.   

Abstract

Perineuronal nets (PNNs) are an extracellular matrix structure rich in chondroitin sulfate proteoglycans (CSPGs), which preferentially encase parvalbumin-containing (PV+) interneurons. PNNs restrict cortical network plasticity but the molecular mechanisms involved are unclear. We found that reactivation of ocular dominance plasticity in the adult visual cortex induced by chondroitinase ABC (chABC)-mediated PNN removal requires intact signaling by the neurotrophin receptor TRKB in PV+ neurons. Additionally, we demonstrate that chABC increases TRKB phosphorylation (pTRKB), while PNN component aggrecan attenuates brain-derived neurotrophic factor (BDNF)-induced pTRKB in cortical neurons in culture. We further found that protein tyrosine phosphatase σ (PTPσ, PTPRS), receptor for CSPGs, interacts with TRKB and restricts TRKB phosphorylation. PTPσ deletion increases phosphorylation of TRKB in vitro and in vivo in male and female mice, and juvenile-like plasticity is retained in the visual cortex of adult PTPσ-deficient mice (PTPσ+/-). The antidepressant drug fluoxetine, which is known to promote TRKB phosphorylation and reopen critical period-like plasticity in the adult brain, disrupts the interaction between TRKB and PTPσ by binding to the transmembrane domain of TRKB. We propose that both chABC and fluoxetine reopen critical period-like plasticity in the adult visual cortex by promoting TRKB signaling in PV+ neurons through inhibition of TRKB dephosphorylation by the PTPσ-CSPG complex.SIGNIFICANCE STATEMENT Critical period-like plasticity can be reactivated in the adult visual cortex through disruption of perineuronal nets (PNNs) by chondroitinase treatment, or by chronic antidepressant treatment. We now show that the effects of both chondroitinase and fluoxetine are mediated by the neurotrophin receptor TRKB in parvalbumin-containing (PV+) interneurons. We found that chondroitinase-induced visual cortical plasticity is dependent on TRKB in PV+ neurons. Protein tyrosine phosphatase σ (PTPσ, PTPRS), a receptor for PNNs, interacts with TRKB and inhibits its phosphorylation, and chondroitinase treatment or deletion of PTPσ increases TRKB phosphorylation. Antidepressant fluoxetine disrupts the interaction between TRKB and PTPσ, thereby increasing TRKB phosphorylation. Thus, juvenile-like plasticity induced by both chondroitinase and antidepressant treatment is mediated by TRKB activation in PV+ interneurons.
Copyright © 2021 Lesnikova et al.

Entities:  

Keywords:  BDNF; CSPG; PTPRS; RPTPσ; chABC; perineuronal nets

Year:  2020        PMID: 33293360      PMCID: PMC7880295          DOI: 10.1523/JNEUROSCI.2228-20.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

Review 1.  A neurotrophic model for stress-related mood disorders.

Authors:  Ronald S Duman; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2006-04-21       Impact factor: 13.382

2.  p75 Neurotrophin Receptor Activation Regulates the Timing of the Maturation of Cortical Parvalbumin Interneuron Connectivity and Promotes Juvenile-like Plasticity in Adult Visual Cortex.

Authors:  Elie Baho; Bidisha Chattopadhyaya; Marisol Lavertu-Jolin; Raffaele Mazziotti; Patricia N Awad; Pegah Chehrazi; Marianne Groleau; Celine Jahannault-Talignani; Elvire Vaucher; Fabrice Ango; Tommaso Pizzorusso; Laura Baroncelli; Graziella Di Cristo
Journal:  J Neurosci       Date:  2019-04-01       Impact factor: 6.167

3.  Environmental enrichment in adulthood promotes amblyopia recovery through a reduction of intracortical inhibition.

Authors:  Alessandro Sale; José Fernando Maya Vetencourt; Paolo Medini; Maria Cristina Cenni; Laura Baroncelli; Roberto De Pasquale; Lamberto Maffei
Journal:  Nat Neurosci       Date:  2007-04-29       Impact factor: 24.884

Review 4.  Environment and brain plasticity: towards an endogenous pharmacotherapy.

Authors:  Alessandro Sale; Nicoletta Berardi; Lamberto Maffei
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

Review 5.  Neuronal plasticity: beyond the critical period.

Authors:  Mark Hübener; Tobias Bonhoeffer
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

6.  Disruption of the perineuronal net in the hippocampus or medial prefrontal cortex impairs fear conditioning.

Authors:  Michael J Hylin; Sara A Orsi; Anthony N Moore; Pramod K Dash
Journal:  Learn Mem       Date:  2013-04-16       Impact factor: 2.460

7.  PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration.

Authors:  Yingjie Shen; Alan P Tenney; Sarah A Busch; Kevin P Horn; Fernando X Cuascut; Kai Liu; Zhigang He; Jerry Silver; John G Flanagan
Journal:  Science       Date:  2009-10-15       Impact factor: 47.728

8.  Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival.

Authors:  A Haapasalo; E Koponen; E Hoppe; G Wong; E Castrén
Journal:  Biochem Biophys Res Commun       Date:  2001-02-09       Impact factor: 3.575

9.  PTPsigma binds and dephosphorylates neurotrophin receptors and can suppress NGF-dependent neurite outgrowth from sensory neurons.

Authors:  Clare Faux; Muhamed Hawadle; Jennifer Nixon; Adam Wallace; Simon Lee; Simon Murray; Andrew Stoker
Journal:  Biochim Biophys Acta       Date:  2007-07-13

10.  Proteoglycan-specific molecular switch for RPTPσ clustering and neuronal extension.

Authors:  Charlotte H Coles; Yingjie Shen; Alan P Tenney; Christian Siebold; Geoffrey C Sutton; Weixian Lu; John T Gallagher; E Yvonne Jones; John G Flanagan; A Radu Aricescu
Journal:  Science       Date:  2011-03-31       Impact factor: 47.728

View more
  7 in total

Review 1.  The extracellular matrix and perineuronal nets in memory.

Authors:  James W Fawcett; Marianne Fyhn; Pavla Jendelova; Jessica C F Kwok; Jiri Ruzicka; Barbara A Sorg
Journal:  Mol Psychiatry       Date:  2022-06-27       Impact factor: 15.992

2.  Editorial: Perineuronal Nets as Therapeutic Targets for the Treatment of Neuropsychiatric Disorders.

Authors:  Caroline A Browne; Katherine Conant; Amy W Lasek; Juan Nacher
Journal:  Front Synaptic Neurosci       Date:  2022-06-10

Review 3.  Implantable Biomaterials for Peripheral Nerve Regeneration-Technology Trends and Translational Tribulations.

Authors:  Angela Sanchez Rezza; Yalcin Kulahci; Vijay S Gorantla; Fatih Zor; Norman M Drzeniek
Journal:  Front Bioeng Biotechnol       Date:  2022-04-27

4.  Antidepressant drugs act by directly binding to TRKB neurotrophin receptors.

Authors:  Plinio C Casarotto; Mykhailo Girych; Senem M Fred; Vera Kovaleva; Rafael Moliner; Giray Enkavi; Caroline Biojone; Cecilia Cannarozzo; Madhusmita Pryiadrashini Sahu; Katja Kaurinkoski; Cecilia A Brunello; Anna Steinzeig; Frederike Winkel; Sudarshan Patil; Stefan Vestring; Tsvetan Serchov; Cassiano R A F Diniz; Liina Laukkanen; Iseline Cardon; Hanna Antila; Tomasz Rog; Timo Petteri Piepponen; Clive R Bramham; Claus Normann; Sari E Lauri; Mart Saarma; Ilpo Vattulainen; Eero Castrén
Journal:  Cell       Date:  2021-02-18       Impact factor: 41.582

Review 5.  LAR Receptor Tyrosine Phosphatase Family in Healthy and Diseased Brain.

Authors:  Francisca Cornejo; Bastián I Cortés; Greg M Findlay; Gonzalo I Cancino
Journal:  Front Cell Dev Biol       Date:  2021-12-13

Review 6.  Non-Cell-Autonomous Factors Implicated in Parvalbumin Interneuron Maturation and Critical Periods.

Authors:  Rachel Gibel-Russo; David Benacom; Ariel A Di Nardo
Journal:  Front Neural Circuits       Date:  2022-04-26       Impact factor: 3.492

7.  Postnatal Sox6 Regulates Synaptic Function of Cortical Parvalbumin-Expressing Neurons.

Authors:  Hermany Munguba; Bidisha Chattopadhyaya; Stephan Nilsson; Josianne N Carriço; Fatima Memic; Polina Oberst; Renata Batista-Brito; Ana Belen Muñoz-Manchado; Michael Wegner; Gordon Fishell; Graziella Di Cristo; Jens Hjerling-Leffler
Journal:  J Neurosci       Date:  2021-09-09       Impact factor: 6.167

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.